Leang Yit J, Hensman Chrys S, Paul Eldho, Kong Joseph C H, Burton Paul R, Brown Wendy A
Department of Surgery, School of Translational Medicine, Monash University, Level 6, Alfred Centre, 99 Commercial Road, Melbourne, VIC, 3004, Australia.
Department of Oesophago-gastric and Bariatric Surgery, The Alfred Hospital, Melbourne, VIC, Australia.
J Robot Surg. 2025 May 12;19(1):214. doi: 10.1007/s11701-025-02355-9.
The robotic approach to metabolic bariatric surgery (MBS) is becoming more popular despite limited data supporting beneficial outcomes. The objective of this study was to evaluate the early outcomes of robotic MBS in Australia. An observational analysis of prospectively maintained data from the Australian arm of the Australia and New Zealand Bariatric Surgery Registry between 2014 to June 2022 were conducted. All patients who underwent robotic MBS (RMBS) were propensity score matched 1:1 to laparoscopic MBS (LMBS) within the Registry. Clinical outcomes were compared using conditional logistic regression analyses. A total of 66,232 patients were included (LMBS n = 65,322; RMBS n = 910) in the analysis. The majority of RMBS were gastric or duodenal-ileal bypasses, significantly higher than the LMBS cohort (49.6 vs 24.3%, p < 0.0001) and more were revisional procedures (26% vs 19.6%, p < 0.0001). On direct comparison, there were significantly more defined adverse events in the RMBS group. When adjusted for cofounders, clinical outcomes of RMBS were comparable to LMBS with no increased risks of defined adverse events or complications.
尽管支持有益结果的数据有限，但机器人辅助代谢性减肥手术（MBS）的方法正变得越来越流行。本研究的目的是评估澳大利亚机器人辅助MBS的早期结果。对2014年至2022年6月期间澳大利亚和新西兰减肥手术登记处澳大利亚分部前瞻性收集的数据进行了观察性分析。登记处内所有接受机器人辅助MBS（RMBS）的患者与腹腔镜MBS（LMBS）进行1:1倾向评分匹配。使用条件逻辑回归分析比较临床结果。分析共纳入66232例患者（LMBS组n = 65322；RMBS组n = 910）。大多数RMBS为胃或十二指肠-回肠旁路手术，显著高于LMBS队列（49.6%对24.3%，p < 0.0001），且更多为翻修手术（26%对19.6%，p < 0.0001）。直接比较时，RMBS组明确的不良事件明显更多。在对混杂因素进行调整后，RMBS的临床结果与LMBS相当，明确不良事件或并发症的风险没有增加。
